Skip to main content

Advertisement

SpringerLink
Log in

A rare case of fluid overload-associated large B-cell lymphoma and antigen loss at relapse

  • Case Report
  • Published:
Journal of Hematopathology Aims and scope Submit manuscript

Abstract

Fluid overload-associated large B-cell lymphoma (FO-LBCL) is a new addition to the list of large B-cell lymphomas in the 5th edition of the World Health Organization Classification of Haematolymphoid Tumours (WHO-HAEM5). This report presents an unusual case of FO-LBCL with partial B cell antigen loss at relapse and reviews the characteristics, treatment, and prognosis of these patients to enhance our understanding of this disease. Immunophenotyping was performed through immunohistochemistry and flow cytometry. Immunoglobulin gene rearrangements were analyzed using BIOMED-2 multiplex primers. MYC, BCL2, and BCL6 gene rearrangements were detected by fluorescent in situ hybridization (FISH). Cell-free DNA (cfDNA) from pleural effusion and peripheral blood was subjected to somatic mutation evaluation using next-generation sequencing (NGS). In 2020, the patient was initially diagnosed with tuberculous pleurisy and received anti-tuberculous drugs. Subsequent testing of the pleural effusion cell block revealed that the large cells to be positive for CD10, CD20, CD79a, PAX5, MUM1, Bcl-2, Bcl-6, and c-myc and negative for CD3, CD30, Cyclin D1, and HHV8. In situ hybridization for Epstein-Barr virus (EBV)-associated mRNA (EBER-ISH) was negative. Additionally, a clonal rearrangement of immunoglobulin heavy locus (IGH) FR2-JH was detected; the results of MYC, BCL2, and BCL6 gene rearrangements were all negative. Following pleural drainage treatment, the patient achieved symptom remission and was diagnosed with large B-cell lymphoma (HHV8-unrelated PEL-like lymphoma). In 2022, the patient was readmitted due to the recurrence of pleural effusion. The pleural effusion cell block revealed a distinct immunophenotype compared to previous findings, positivity for PAX5 and negativity for CD20, CD10, CD3, CD5, CD30, CD38, CD138, CD79a, MUM1, Bcl-2, Bcl-6, Cyclin D1, c-myc, ALK, and HHV8. Identical IGH FR2-JH clonal rearrangement suggested the recurrence of the original clone. CfDNA analysis showed mutations in CD79B, MYD88, CCND3, and DTX1. The patient was ultimately diagnosed with FO-LBCL based on the WHO-HAEM5 classification. Diagnosis of FO-LBCL should be differentiated from primary effusion lymphoma (PEL). The features of this case align with the description of “FO-LBCL” in WHO-HAEM5 and “HHV8 and EBV-negative primary effusion-based lymphoma” in International Consensus Classification (ICC). FO-LBCL patients generally have a more favorable prognosis compared to PEL. In this case, the patient exhibited a favorable prognosis for over 22 months without additional treatment apart from pleural drainage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

The data that support the findings of this study are available on request from the corresponding author ‘Jinning Shi, s8j8n8@126.com’ upon reasonable request.

References

  1. Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E, Bhagat G, Borges AM, Boyer D, Calaminici M, Chadburn A, Chan JKC, Cheuk W, Chng WJ, Choi JK, Chuang SS, Coupland SE, Czader M, Dave SS, de Jong D, Du MQ, Elenitoba-Johnson KS, Ferry J, Geyer J, Gratzinger D, Guitart J, Gujral S, Harris M, Harrison CJ, Hartmann S, Hochhaus A, Jansen PM, Karube K, Kempf W, Khoury J, Kimura H, Klapper W, Kovach AE, Kumar S, Lazar AJ, Lazzi S, Leoncini L, Leung N, Leventaki V, Li XQ, Lim MS, Liu WP, Louissaint A Jr, Marcogliese A, Medeiros LJ, Michal M, Miranda RN, Mitteldorf C, Montes-Moreno S, Morice W, Nardi V, Naresh KN, Natkunam Y, Ng SB, Oschlies I, Ott G, Parrens M, Pulitzer M, Rajkumar SV, Rawstron AC, Rech K, Rosenwald A, Said J, Sarkozy C, Sayed S, Saygin C, Schuh A, Sewell W, Siebert R, Sohani AR, Tooze R, Traverse-Glehen A, Vega F, Vergier B, Wechalekar AD, Wood B, Xerri L, Xiao W (2022) The 5th edition of the World Health Organization classification of haematolymphoid tumours: Lymphoid Neoplasms. Leukemia 36(7):1720–1748. https://doi.org/10.1038/s41375-022-01620-2

  2. Shimada K, Hayakawa F, Kiyoi H (2018) Biology and management of primary effusion lymphoma. Blood 132(18):1879–1888. https://doi.org/10.1182/blood-2018-03-791426

    Article  CAS  PubMed  Google Scholar 

  3. Kaji D, Ota Y, Sato Y, Nagafuji K, Ueda Y, Okamoto M, Terasaki Y, Tsuyama N, Matsue K, Kinoshita T, Yamamoto G, Taniguchi S, Chiba S, Ohshima K, Izutsu K (2020) Primary human herpesvirus 8-negative effusion-based lymphoma: a large B-cell lymphoma with favorable prognosis. Blood Adv 4(18):4442–4450. https://doi.org/10.1182/bloodadvances.2020002293

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, Swerdlow SH, Anderson KC, Brousset P, Cerroni L, de Leval L, Dirnhofer S, Dogan A, Feldman AL, Fend F, Friedberg JW, Gaulard P, Ghia P, Horwitz SM, King RL, Salles G, San-Miguel J, Seymour JF, Treon SP, Vose JM, Zucca E, Advani R, Ansell S, Au WY, Barrionuevo C, Bergsagel L, Chan WC, Cohen JI, d’Amore F, Davies A, Falini B, Ghobrial IM, Goodlad JR, Gribben JG, Hsi ED, Kahl BS, Kim WS, Kumar S, LaCasce AS, Laurent C, Lenz G, Leonard JP, Link MP, Lopez-Guillermo A, Mateos MV, Macintyre E, Melnick AM, Morschhauser F, Nakamura S, Narbaitz M, Pavlovsky A, Pileri SA, Piris M, Pro B, Rajkumar V, Rosen ST, Sander B, Sehn L, Shipp MA, Smith SM, Staudt LM, Thieblemont C, Tousseyn T, Wilson WH, Yoshino T, Zinzani PL, Dreyling M, Scott DW, Winter JN, Zelenetz AD (2022) The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee. Blood 140(11):1229–1253. https://doi.org/10.1182/blood.2022015851

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Shimada K, Hayakawa F, Kiyoi H (2018) Biology and management of primary effusion lymphoma. Blood 132(18):1879–1888. https://doi.org/10.1182/blood-2018-03-791426

    Article  CAS  PubMed  Google Scholar 

  6. Shin J, Lee JO, Choe JY, Bang SM, Lee JS (2017) Human herpesvirus 8-unrelated primary effusion lymphoma-like lymphoma in an elderly Korean patient with a good response to rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone. Cancer Res Treat 49(1):274–278. https://doi.org/10.4143/crt.2016.076

    Article  PubMed  Google Scholar 

  7. Gisriel SD, Yuan J, Braunberger RC, Maracaja DLV, Chen X, Wu X, McCracken J, Chen M, Xie Y, Brown LE, Li P, Zhou Y, Sethi T, McHenry A, Hauser RG, Paulson N, Tang H, Hsi ED, Wang E, Zhang QY, Young KH, Xu ML, Pan Z (2022) Human herpesvirus 8-negative effusion-based large B-cell lymphoma: a distinct entity with unique clinicopathologic characteristics. Mod Pathol 35(10):1411–1422. https://doi.org/10.1038/s41379-022-01091-x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Kubota T, Sasaki Y, Shiozawa E, Takimoto M, Hishima T, Chong JM (2018) Age and CD20 expression are significant prognostic factors in human herpes virus-8-negative effusion-based lymphoma. Am J Surg Pathol 42(12):1607–1616. https://doi.org/10.1097/PAS.0000000000001168

    Article  PubMed  Google Scholar 

  9. Mendeville M, Roemer MGM, van den Hout MFCM, Los-de Vries GT, Bladergroen R, Stathi P, Hijmering NJ, Rosenwald A, Ylstra B, de Jong D (2019) Aggressive genomic features in clinically indolent primary HHV8-negative effusion-based lymphoma. Blood 133(4):377–380. https://doi.org/10.1182/blood-2017-12-822171

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Chen R, Zhou D, Wang L, Zhu L, Ye X (2022) MYD88 L265P and CD79B double mutations type (MCD type) of diffuse large B-cell lymphoma: mechanism, clinical characteristics, and targeted therapy. Ther Adv Hematol 13:20406207211072840. https://doi.org/10.1177/20406207211072839

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Schmitz R, Wright GW, Huang DW, Johnson CA, Phelan JD, Wang JQ, Roulland S, Kasbekar M, Young RM, Shaffer AL, Hodson DJ, Xiao W, Yu X, Yang Y, Zhao H, Xu W, Liu X, Zhou B, Du W, Chan WC, Jaffe ES, Gascoyne RD, Connors JM, Campo E, Lopez-Guillermo A, Rosenwald A, Ott G, Delabie J, Rimsza LM, Tay Kuang Wei K, Zelenetz AD, Leonard JP, Bartlett NL, Tran B, Shetty J, Zhao Y, Soppet DR, Pittaluga S, Wilson WH, Staudt LM (2018) Genetics and pathogenesis of diffuse large b-cell lymphoma. N Engl J Med 378(15):1396–1407. https://www.nejm.org/doi/https://doi.org/10.1056/NEJMoa1801445

  12. Bitar C, Hile G, Brown NA, Fullen DR, Lowe L, Tejasvi T, Wilcox RA, Harms PW, Chan MP, Bresler SC, Hristov AC (2021) Immunophenotypic switch in cutaneous t-cell lymphoma: a series of three cases and review of the literature. J Cutan Pathol 48(7):986–994. https://doi.org/10.1111/cup.14026

    Article  PubMed  Google Scholar 

Download references

Funding

This study was not supported by any funding.

Author information

Author notes

  1. Xue Yan and Bin Chen contributed equally to this work.

Authors and Affiliations

  1. Department of Hematology, The Affiliated Jiangning Hospital With Nanjing Medical University, Hushan Road, Jiangning District, Nanjing, 211100, Jiangsu, China

    Xue Yan, Hongxia Jing, Zhinan Yang, Ting Zhang & Jinning Shi

  2. Sino-US Diagnostics Lab, Tianjin Enterprise Key Laboratory of AI-Aided Hematopathology Diagnosis, Tianjin, 300385, China

    Bin Chen & Yani Lin

Authors
  1. Xue Yan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bin Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hongxia Jing
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zhinan Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ting Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yani Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jinning Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Yani Lin or Jinning Shi.

Ethics declarations

Ethical approval

For this type of study formal consent is not required.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Consent for publication

Consent for publication was obtained for every individual person’s data included in the study.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 444 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yan, X., Chen, B., Jing, H. et al. A rare case of fluid overload-associated large B-cell lymphoma and antigen loss at relapse. J Hematopathol 16, 235–240 (2023). https://doi.org/10.1007/s12308-023-00566-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12308-023-00566-3

Keywords

Search

Navigation